Effect of caveolin-1 scaffolding peptide and 17β-estradiol on intracellular Ca2+ kinetics evoked by angiotensin II in human vascular smooth muscle cells

American Journal of Physiology - Cell Physiology

Volumn 293, Issue 6, 2007, Pages

  Méndez Bolaina, Enrique ^a,b   Sánchez González, Javier ^c   Ramírez Sánchez, Israel ^a,d   Ocharán Hernández, Esther ^a   Núñez Sánchez, Marisol ^a   Meaney Mendiolea, Eduardo ^e   Meaney, Alejandra ^e   Asbun Bojalil, Juan ^a   Miliar García, Angel ^a   Olivares Corichi, Ivonne ^a   Ceballos Reyes, Guillermo ^a  

^a INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^b UNIVERSIDAD VERACRUZANA   (Mexico)

^c Universidad de Falcón   (Mexico)

^d HOSPITAL DE PEDIATRÍA   (Mexico)

^e Instituto de Seguridad   (Mexico)

Author keywords

Angiotensin receptors; Angiotensin type 1 and 2 receptors; Estrogen receptors; Intracellular signaling; Phosphatidylinositol 3 kinase; Tissue culture

Indexed keywords

ANGIOTENSIN II; CALCIUM; CAVEOLIN 1; CAVEOLIN 2; CAVEOLIN 3; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; PHOSPHATIDYLINOSITOL 3 KINASE; SCAFFOLD PROTEIN;

APOPTOSIS; ARTICLE; CELL GROWTH; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; IMMUNOPRECIPITATION; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANGIOTENSIN II; CALCIUM; CAVEOLIN 1; CELLS, CULTURED; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; MALE; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; SIGNAL TRANSDUCTION;

MAMMALIA;

EID: 37149049721     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00519.2006     Document Type: Article

References (47)

1. Abdalla S, Lother H, Abdel-tawab AM, Quitterer U. The angiotensin II AT2 receptor is an AT1 receptor antagonist. J Biol Chem 276: 39721-39726, 2001.
2. Bkaily G, Pothier P, D'Orleans-Juste P, Simaan M, Jacques D, Jaalouk D, Belzile F, Hassan G, Boutin C, Haddad G, Neugebauer W. The use of confocal microscopy in the investigation of cell structure and function in the heart, vascular endothelium and smooth muscle cells. Mol Cell Biochem 172: 171-194, 1997.
3. Bkaily G, Sleiman S, Stephan J, Asselin C, Choufani S, Kamal M, Jacques D, Gobeil, F Jr, D'Orleans-Juste P. Angiotensin II AT1 receptor internalization, translocation and de novo synthesis modulate cytosolic and nuclear calcium in human vascular smooth muscle cells. Can J Physiol Pharmacol 81: 274-287, 2003.
4. Carman CV, Lisanti MP, Benovic JL. Regulation of G protein-coupled receptor kinases by caveolin. J Biol Chem 274: 8858-8864, 1999.
5. Cerecedo D, Martinez-Rojas D, Chavez O, Martinez-Perez F, Garcia-Sierra F, Rendon A, Mornet D, Mondragon R. Platelet adhesion: structural and functional diversity of short dystrophin and utrophins in the formation of dystrophin-associated-protein complexes related to actin dynamics. Thromb Haemost 94: 1203-1212, 2005.
6. Chini B, Parenti M. G-protein coupled receptors in lipid rafts and caveolae: how, when and why do they go there? J Mol Endocrinol 32: 325-338, 2004.
7. Christ M, Wehling M. Cardiovascular steroid actions: swift swallows or sluggish snails? Cardiovasc Res 40: 34-44, 1998.
8. Cohen AW, Hnasko R, Schubert W, Lisanti MP. Role of caveolae and caveolins in health and disease. Physiol Rev 84: 1341-1379, 2004.
9. de Gasparo M, Catt KJ, Inagami T, Wright JW, Unger T. International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev 52: 415-472, 2000.
10. 2 angiotensin receptors in rat anococcygeus smooth muscle. J Pharmacol Exp Ther 303: 333-339, 2002.
11. Falkenstein E, Tillmann HC, Christ M, Feuring M, Wehling M. Multiple actions of steroid hormones - a focus on rapid, nongenomic effects. Pharmacol Rev 52: 513-556, 2000.
12. Gherghiceanu M, Popescu LM. Caveolar nanospaces in smooth muscle cells. J Cell Mol Med 10: 519-528, 2006.
13. Gratton JP, Bernatchez P, Sessa WC. Caveolae and caveolins in the cardiovascular system. Circ Res 94: 1408-1417, 2004.
14. Ishizaka N, Griendling KK, Lassegue B, Alexander RW. Angiotensin II type 1 receptor: relationship with caveolae and caveolin after initial agonist stimulation. Hypertension 32: 459-466, 1998.
15. Je HD, Gallant C, Leavis PC, Morgan KG. Caveolin-1 regulates contractility in differentiated vascular smooth muscle. Am J Physiol Heart Circ Physiol 286: H91-H98, 2004.
16. Kaschina E, Unger T. Angiotensin AT1/AT2 receptors: regulation, signalling and function. Blood Press 12: 70-88, 2003.
17. Kim S, Iwao H. Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases. Pharmacol Rev 52: 11-34, 2000.
18. Lavoie JL, Sigmund CD. Minireview: overview of the renin angiotensin system-an endocrine and paracrine system. Endocrinology 144: 2179-2183, 2003.
19. Liu P, Rudick M, Anderson RG. Multiple functions of caveolin-1. J Biol Chem 277: 41295-41298, 2002.
20. Marx J. Caveolae: a once-elusive structure gets some respect. Science 294: 1862-1865, 2001.
21. Nadal A, Diaz M, Valverde MA. The estrogen trinity: membrane, cytosolic, and nuclear effects. News Physiol Sci 16: 251-255, 2001.
22. Nickenig G, Baumer AT, Grohe C, Kahlert S, Strehlow K, Rosenkranz S, Stablein A, Beckers F, Smits JF, Daemen MJ, Vetter H, Bohm M. Estrogen modulates AT1 receptor gene expression in vitro and in vivo. Circulation 97: 2197-2201, 1998.
23. 1 receptor gene expression in vascular smooth muscle cells. Circulation 102: 1828-1833, 2000.
24. Ocharan E, Asbun J, Calzada C, Mendez E, Nunez M, Medina R, Suarez G, Meaney E, Ceballos G. Caveolin scaffolding peptide-1 interferes with norepinephrine-induced PLC-beta activation in cultured rat vascular smooth muscle cells. J Cardiovasc Pharmacol 46: 615-621, 2005.
25. Oka N, Yamamoto M, Schwencke C, Kawabe J, Ebina T, Ohno S, Couet J, Lisanti MP, Ishikawa Y. Caveolin interaction with protein kinase C. Isoenzyme dependent regulation of kinase activity by the caveolin scaffolding domain peptide. J Biol Chem 272: 33416-33421, 1997.
26. Okamoto T, Schlegel A, Scherer PE, Lisanti MP. Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes" at the plasma membrane. J Biol Chem 273: 5419-5422, 1998.
27. Parton RG. Cell biology. Life without caveolae. Science 293: 2404-2405, 2001.
28. Popescu LM, Gherghiceanu M, Mandache E, Cretoiu D. Caveolae in smooth muscles: nanocontacts. J Cell Mol Med 10: 960-990, 2006.
29. Ramirez-Sanchez I, Ceballos-Reyes G, Rosas-Vargas H, Cerecedo-Mercado D, Zentella-Dehesa A, Salamanca F, Coral-Vazquez RM. Expression and function of utrophin associated protein complex in stretched endothelial cells: dissociation and activation of eNOS. Front Biosci 12: 1956-1962, 2007.
30. Razani B, Woodman SE, Lisanti MP. Caveolae: from cell biology to animal physiology. Pharmacol Rev 54: 431-467, 2002.
31. 2+ signaling. Am J Physiol Heart Circ Physiol 284: H779-H789, 2003.
32. Schlegel A, Wang C, Katzenellenbogen BS, Pestell RG, Lisanti MP. Caveolin-1 potentiates estrogen receptor alpha (ERalpha) signaling. Caveolin-1 drives ligand-independent nuclear translocation and activation of ERalpha. J Biol Chem 274: 33551-33556, 1999.
33. Schlegel A, Schwab RB, Scherer PE, Lisanti MP. A role for the caveolin scaffolding domain in mediating the membrane attachment of caveolin-1. The caveolin scaffolding domain is both necessary and sufficient for membrane binding in vitro. J Biol Chem 274: 22660-22667, 1999.
34. Segars JH, Driggers PH. Estrogen action and cytoplasmic signaling cascades. Part I: membrane-associated signaling complexes. Trends Endocrinol Metab 13: 349-354, 2002.
35. 2+-channel current in vascular smooth muscle cells is inhibited by lavendustin-A and LY-294002. Pflügers Arch 437: 317-323, 1999.
36. 2+ kinetics in rat coronary endothelial cells are exerted via aromatization to estrogens. Am J Physiol Heart Circ Physiol 287: H63-H71, 2004.
37. Smart EJ, Graf GA, McNiven MA, Sessa WC, Engelman JA, Scherer PE, Okamoto T, Lisanti MP. Caveolins, liquid-ordered domains, and signal transduction. Mol Cell Biol 19: 7289-7304, 1999.
38. Takahashi T, Taniguchi T, Konishi H, Kikkawa U, Ishikawa Y, Yokoyama M. Activation of Akt/protein kinase B after stimulation with angiotensin II in vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 276: H1927-H1934, 1999.
39. Takekoshi K, Ishii K, Shibuya S, Kawakami Y, Isobe K, Nakai T. Angiotensin II type 2 receptor counter-regulates type 1 receptor in catecholamine synthesis in cultured porcine adrenal medullary chromaffin cells. Hypertension 39: 142-148, 2002.
40. Taubman MB. Angiotensin II: a vasoactive hormone with ever increasing biological roles. Circ Res 92: 9-11, 2003.
41. Timmermans PB, Wong PC, Chiu AT, Herblin WF, Benfield P, Carini DJ, Lee RJ, Wexler RR, Saye JA, Smith RD. Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev 45: 205-251, 1993.
42. Tostes RC, Nigro D, Fortes ZB, Carvalho MH. Effects of estrogen on the vascular system. Braz J Med Biol Res 36: 1143-1158, 2003.
43. Touyz RM, EL. Schiffrin signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells. Pharmacol Rev 52: 639-672, 2000.
44. Tsutsumi Y, Matsubara H, Masaki H, Kurihara H, Murasawa S, Takai S, Miyazaki M, Nozawa Y, Ozono R, Nakagawa K, Miwa T, Kawada N, Mori Y, Shibasaki Y, Tanaka Y, Fujiyama S, Koyama Y, Fujiyama A, Takahashi H, Iwasaka T. Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation. J Clin Invest 104: 925-935, 1999.
45. Viard P, Butcher AJ, Halet G, Davies A, Nurnberg B, Heblich F, Dolphin AC. PI3K promotes voltage-dependent calcium channel trafficking to the plasma membrane. Nat Neurosci 7: 939-946, 2004.
46. Wyse BD, Prior IA, Qian H, Morrow IC, Nixon S, Muncke C, Kurzchalia TV, Thomas WG, Parton RG, Hancock JF. Caveolin interacts with the angiotensin II type 1 receptor during exocytic transport but not at the plasma membrane. J Biol Chem 278: 23738-23746, 2003.
47. Xue B, Pamidimukkala J, Lubahn D, Hay M. Estrogen receptor-α mediates estrogen protection from angiotensin ii-induced hypertension in conscious female mice. Am J Physiol Heart Circ Physiol 292: H1770-H1776, 2007.